- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: 5 mg Linagliptin (Tradjenta)
Total 1272 results
-
University of MiamiWithdrawn
-
PHARMENTERPRISES LLCCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesTaiwan, Korea, Republic of, South Africa, Hong Kong, Brazil, China, Ukraine
-
Boryung Pharmaceutical Co., LtdWithdrawn
-
Sadat City UniversityBeni-Suef UniversityCompleted
-
BayerCompletedHeart FailureBelgium, France, Spain, Greece, Portugal, Japan, United States, Singapore, Austria, Germany, Korea, Republic of, Poland, Australia, Israel, Netherlands, Switzerland, Taiwan, Bulgaria, Canada, Czechia, Denmark, Hungary, Italy, Sweden, United...
-
PfizerTerminated
-
Kyowa Kirin Co., Ltd.Completed
-
Suzhou Kintor Pharmaceutical Inc,Suzhou Koshine Biomedica, Inc.Active, not recruiting
-
University of PennsylvaniaNational Heart, Lung, and Blood Institute (NHLBI); National Institute of Arthritis... and other collaboratorsActive, not recruitingGranulomatosis With PolyangiitisUnited States, Canada
-
Actinogen MedicalAvance ClinicalCompletedMild Cognitive Impairment | Alzheimer's DiseaseAustralia
-
University of Nevada, RenoAugusta UniversityCompleted
-
Merck Sharp & Dohme LLCCompleted
-
BayerCompletedHeart FailureBelgium, France, Switzerland, United States, Spain, Greece, Japan, Singapore, Austria, Germany, Korea, Republic of, Poland, Denmark, Israel, Netherlands, Taiwan, Bulgaria, Canada, Sweden, Czechia, Australia, Italy, Hungary, United Kingdom
-
Conatus Pharmaceuticals Inc.CompletedLiver Diseases | Fibrosis | Non-alcoholic SteatohepatitisUnited States, Spain, Germany
-
CytokineticsEnrolling by invitationSymptomatic Hypertrophic Cardiomyopathy (HCM)United States, France, Israel, Spain, United Kingdom, Italy, Portugal, Poland, Hungary, Denmark, Netherlands, Germany, Czechia
-
PfizerWithdrawnDementia | Alzheimer's Disease | Dimebon | Investigational Drug
-
BayerMerck Sharp & Dohme LLC; Duke Clinical Research Institute; Canadian VIGOUR CentreCompletedChronic Heart Failure With Preserved Ejection FractionSpain, United States, Belgium, Singapore, Taiwan, Canada, Japan, Italy, Austria, Bulgaria, Germany, Greece, Israel, Poland, Portugal, Hungary, Russian Federation, Argentina, Colombia, Malaysia, South Africa
-
AstraZenecaParexelCompletedType 2 Diabetes MellitusUnited States
-
Oslo University HospitalVestre Viken Hospital Trust; University of Oslo; The Research Council of Norway; University Hospital, Akershus and other collaboratorsRecruitingGlucose Metabolism Disorders | Impaired Glucose Tolerance | Insulin SensitivityNorway
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type II
-
Janssen Research & Development, LLCTerminatedAlzheimer DiseaseFrance, Spain, Netherlands, Belgium, Germany, Sweden
-
Eisai Co., Ltd.Completed
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Janssen Pharmaceutical K.K.Completed
-
Ferring PharmaceuticalsTerminatedChronic Idiopathic ConstipationSweden, Canada, Hungary, United States, Brazil, South Africa, Czech Republic, Germany, Mexico, Poland, Slovakia, United Kingdom
-
Regional Hospital HolstebroCompleted
-
GlaxoSmithKlineCompletedGastroparesisUnited States, Australia, Belgium, United Kingdom, Canada, Sweden
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Unknown
-
Samsung Medical CenterCompletedRenal Insufficiency | Albuminuria | Type2 Diabetes MellitusKorea, Republic of
-
Teva Pharmaceuticals USACompleted
-
CytokineticsJi Xing Pharmaceuticals (Shanghai) Co., Ltd.CompletedObstructive Hypertrophic Cardiomyopathy (oHCM)United States, France, Spain, Portugal, Germany, China, United Kingdom, Israel, Netherlands, Denmark, Czechia, Hungary, Italy, Poland
-
Merck Sharp & Dohme LLCPfizerCompleted
-
Merck Sharp & Dohme LLCPfizerCompleted
-
RezoluteRecruitingCongenital HyperinsulinismBulgaria, Canada, Denmark, France, Georgia, Germany, Greece, Israel, Oman, Qatar, Saudi Arabia, Spain, Turkey, United Arab Emirates, United Kingdom, Vietnam
-
Bio-innova Co., LtdNot yet recruiting
-
Institute of Hematology & Blood Diseases HospitalNot yet recruitingThe Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA
-
Bial - Portela C S.A.CompletedCardiovascular DiseasesUnited Kingdom
-
Jadran Galenski laboratorij d.d.CompletedPrimary Open Angle Glaucoma of Both EyesRussian Federation
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Boehringer IngelheimTerminated
-
Janssen Research & Development, LLCCompleted
-
Teva Pharmaceuticals USACompleted
-
Heart Care FoundationFondazione dell'Associazione Medici DiabetologiCompletedDiabetes Mellitus, Type 2 | Left Ventricular Systolic DysfunctionItaly
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus (T2DM)